[Different response of the superficial and deep lymph nodes to therapy in malignant lymphoreticulopathies].
D000328:Adult; D002699:Chlorambucil / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008220:Lymphography; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use*; D012186:Retroperitoneal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy* / Q000532:radiotherapy
D002699:Chlorambucil; D003520:Cyclophosphamide; D011241:Prednisone
Réponse différente des ganglions superficiels et des ganglions profonds a la thérapeutique, dans les lymphoréticulopathies malignes.